Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma

NCT00016055 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: lymphokine-activated killer cells
DRUG: temozolomide

Sponsor

St. Luke's Medical Center